UNIGE document Scientific Article
previous document  unige:46012  next document
add to browser collection
Title

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry
Authors
Zufferey, Pascal
Dudler, Jean
Scherer, Almut
Finckh, Axel
Published in Joint, Bone, Spine. 2013, vol. 80, no. 2, p. 160-4
Abstract In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis (RA) patients is not limited by stringent requirements from health authorities. The goals of this study were to: determine the characteristics of the Swiss patients at the initiation of biologics, compare them with other countries and evaluate whether different disease activity levels at initiation of therapy, resulting from distinct access to these treatment, influence their effectiveness.
Keywords Adult — Aged — Antirheumatic Agents/therapeutic use — Arthritis, Rheumatoid/drug therapy/epidemiology/physiopathology — Biological Therapy — Cross-Cultural Comparison — Europe/epidemiology — Female — Humans — Male — Middle Aged — Registries/statistics & numerical data — Retrospective Studies — Switzerland/epidemiology — Treatment Outcome
Identifiers
PMID: 22771133
Full text
Article (Published version) (393 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format) 		ZUFFEREY, Pascal et al. Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry. In: Joint, Bone, Spine, 2013, vol. 80, n° 2, p. 160-4. doi: 10.1016/j.jbspin.2012.05.003 https://archive-ouverte.unige.ch/unige:46012

434 hits

0 download

Contact an author

Update request

Update

Deposited on : 2015-01-29

Export document
Format :
Citation style :